CDK8 and pancreatic neoplasm: Despite the diverse transcriptional resistance programs observed across tissue types, CDK8/19 inhibition completely prevented lung and colon cancer cells from developing resistance to ERK inhibition (Fig. 2g, bottom), and markedly delayed the emergence of resistance in pancreatic cancer cells.